Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,778 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor.
Licciardello MP, Ringler A, Markt P, Klepsch F, Lardeau CH, Sdelci S, Schirghuber E, Müller AC, Caldera M, Wagner A, Herzog R, Penz T, Schuster M, Boidol B, Dürnberger G, Folkvaljon Y, Stattin P, Ivanov V, Colinge J, Bock C, Kratochwill K, Menche J, Bennett KL, Kubicek S. Licciardello MP, et al. Among authors: ivanov v. Nat Chem Biol. 2017 Jul;13(7):771-778. doi: 10.1038/nchembio.2382. Epub 2017 May 22. Nat Chem Biol. 2017. PMID: 28530711
NMR quality control of fragment libraries for screening.
Sreeramulu S, Richter C, Kuehn T, Azzaoui K, Blommers MJJ, Del Conte R, Fragai M, Trieloff N, Schmieder P, Nazaré M, Specker E, Ivanov V, Oschkinat H, Banci L, Schwalbe H. Sreeramulu S, et al. Among authors: ivanov v. J Biomol NMR. 2020 Nov;74(10-11):555-563. doi: 10.1007/s10858-020-00327-9. Epub 2020 Jun 12. J Biomol NMR. 2020. PMID: 32533387 Free PMC article.
Phenotypic assessment of antiviral activity for spiro-annulated oxepanes and azepenes.
Osolodkin DI, Kozlovskaya LI, Iusupov IR, Kurkin AV, Shustova EY, Orlov AA, Khvatov EV, Mutnykh ES, Kurashova SS, Vetrova AN, Yatsenko DO, Goryashchenko AS, Ivanov VN, Lukyanenko ER, Karpova EV, Stepanova DA, Volok VP, Sotskova SE, Dzagurova TK, Karganova GG, Lukashev AN, Ishmukhametov AA. Osolodkin DI, et al. Among authors: ivanov vn. Chem Biol Drug Des. 2024 May;103(5):e14553. doi: 10.1111/cbdd.14553. Chem Biol Drug Des. 2024. PMID: 38789394
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Nov 21:S0140-6736(24)01762-8. doi: 10.1016/S0140-6736(24)01762-8. Online ahead of print. Lancet. 2024. PMID: 39581202
Effectiveness and prediction of treatment adherence to guided internet-based cognitive behavioral therapy for health anxiety: A cohort study in routine psychiatric care.
Österman S, Axelsson E, Forsell E, Svanborg C, Lindefors N, Hedman-Lagerlöf E, Ivanov VZ. Österman S, et al. Among authors: ivanov vz. Internet Interv. 2024 Oct 16;38:100780. doi: 10.1016/j.invent.2024.100780. eCollection 2024 Dec. Internet Interv. 2024. PMID: 39498477 Free PMC article.
The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia.
DiNardo CD, Pratz KW, Panayiotidis P, Wei X, Vorobyev V, Illés Á, Kim I, Ivanov V, Ku G, Miller CL, Zhang M, Tatsch F, Potluri J, Schmidt X, Récher C. DiNardo CD, et al. Among authors: ivanov v. Am J Hematol. 2024 Nov 1. doi: 10.1002/ajh.27515. Online ahead of print. Am J Hematol. 2024. PMID: 39487568 No abstract available.
2,778 results